The six-domain protein gelsolin functions in plasma (extracellular isoform) to disassemble actin filaments as part of the actin scavenging system. The D1 87N or Y mutation in domain 2 facilitates two aberrant proteolytic cleavages affording a 71 residue fragment that is found in amyloid fibrils in humans, putatively causing Familial Amyloidosis of Finnish type (FAF). We have discovered that the protease furin (found in the Golgi and endocytic compartments) and, potentially, related members of the prohormone convertase family effect the initial cleavage. This result allows us to probe the mechanism of this disease in an efficient fashion and provides a clear approach to intervene with small molecules. The second cleavage occurs at an unknown cellular/extracellular location. We have set out to understand the role of the FAF mutations in amyloidogenicity using biophysical studies in vitro (Aim 1) under conditions found in the trans-Golgi (pH 6.5, 200 uM Ca+2) in combination with cell biological studies focusing on both the export and import of gelsolin and fragments thereof in Aim 2, as well as transgenic animal studies in Aim 3. The goals of Aim 1 are to carry out a thermodynamic stability assessment on several different gelsolin constructs in addition to proteolysis sensitivity studies and structural comparisons of the WT and FAF variants to understand how these mutations lead to furin proteolysis. Small molecule inhibitors of the initial 172-173 cleavage will be sought using a cell-based screen. We will also carry out mechanistic and structural studies to better understand gelsolin fibril formation.
In Aim 2, we will use a variety of biochemical, molecular and morphological approaches to further explore the site of processing of mutant gelsolin by furin and potentially other members of the prohormone convertase family. Moreover, we propose to identify the protease(s) involved in the second cleavage step leading to generation of the amyloidogenic fragment.
In Aim 3, two transgenic animal models of FAF will be produced, one having one copy of WT and one copy of D187N plasma gelsolin (+/D187N) and the other having one copy of D187N on the knockout background (-/D187N) to improve our understanding of the relationship between aberrant processing, fibril formation and neurodegeneration. These mice provide a means of testing the small molecule therapeutics that come from Aims 1 and 2. Our long-term goal is to test the amyloid hypothesis in pathology by linking the cell biology and biophysical data to studies on transgenic animals and small molecule inhibitors that prevent misfolding and/or improper processing.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG018917-02
Application #
6624223
Study Section
Special Emphasis Panel (ZRG1-MDCN-1 (01))
Program Officer
Snyder, Stephen D
Project Start
2002-04-15
Project End
2006-03-31
Budget Start
2003-04-01
Budget End
2004-03-31
Support Year
2
Fiscal Year
2003
Total Cost
$533,778
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Haykowsky, Mark J; Nicklas, Barbara J; Brubaker, Peter H et al. (2018) Regional Adipose Distribution and its Relationship to Exercise Intolerance in Older Obese Patients Who Have Heart Failure With Preserved Ejection Fraction. JACC Heart Fail 6:640-649
Hulleman, John D; Kelly, Jeffery W (2015) Genetic ablation of N-linked glycosylation reveals two key folding pathways for R345W fibulin-3, a secreted protein associated with retinal degeneration. FASEB J 29:565-75
Haykowsky, Mark J; Kitzman, Dalane W (2014) Exercise physiology in heart failure and preserved ejection fraction. Heart Fail Clin 10:445-52
Bannykh, Sergei I; Balch, William E; Kelly, Jeffery W et al. (2013) Formation of gelsolin amyloid fibrils in the rough endoplasmic reticulum of skeletal muscle in the gelsolin mouse model of inclusion body myositis: comparative analysis to human sporadic inclusion body myositis. Ultrastruct Pathol 37:304-11
Hulleman, John D; Brown, Steven J; Rosen, Hugh et al. (2013) A high-throughput cell-based Gaussia luciferase reporter assay for identifying modulators of fibulin-3 secretion. J Biomol Screen 18:647-58
Solomon, James P; Page, Lesley J; Balch, William E et al. (2012) Gelsolin amyloidosis: genetics, biochemistry, pathology and possible strategies for therapeutic intervention. Crit Rev Biochem Mol Biol 47:282-96
Hulleman, John D; Balch, William E; Kelly, Jeffery W (2012) Translational attenuation differentially alters the fate of disease-associated fibulin proteins. FASEB J 26:4548-60
Hulleman, John D; Kaushal, Shalesh; Balch, William E et al. (2011) Compromised mutant EFEMP1 secretion associated with macular dystrophy remedied by proteostasis network alteration. Mol Biol Cell 22:4765-75
Bouchecareilh, Marion; Balch, William E (2011) Proteostasis: a new therapeutic paradigm for pulmonary disease. Proc Am Thorac Soc 8:189-95
Solomon, James P; Bourgault, Steve; Powers, Evan T et al. (2011) Heparin binds 8 kDa gelsolin cross-?-sheet oligomers and accelerates amyloidogenesis by hastening fibril extension. Biochemistry 50:2486-98

Showing the most recent 10 out of 24 publications